Related Experiment Video
Updated: Jun 25, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
Sophie Iochmann1, Claire Bléchet, Valérie Chabot
1Inserm U618, Protéases et Vectorisation Pulmonaires, Faculté de Médecine, Université François Rabelais, IFR 135, 10 Boulevard Tonnellé, 37032, Tours Cedex, France. iochmann@med.univ-tours.fr
Abstract:
Tissue Factor Pathway Inhibitor-2 (TFPI-2) is a potent inhibitor of plasmin which activates metalloproteinases (MMPs) involved in extracellular matrix (ECM) degradation. Its secretion in ECM makes TFPI-2 a potential inhibitor to regulate tumour invasion and metastasis. Moreover, TFPI-2 is frequently downregulated, particularly in aggressive cancers. In this study, we silenced TFPI-2 in the NCI-H460 non-small cell lung cancer cell line and evaluated the role of TFPI-2 in cell invasion and its impact on MMPs expression. As the effects of siRNA are transient, the consequences of both gene silencing and restoration to normal expression could be studied kinetically in the same cells. We showed that TFPI-2 expression by NCI-H460 cells was effectively downregulated using specific small interfering RNA and this silencing was associated with an increase in the invasive potential of tumour cells while migration was not affected. We also showed that mRNA levels and protein expression of MMP-2, -3, -9, -14 were not influenced by TFPI-2 silencing. Moreover, the gelatinase activity of MMP-2 and MMP-9 was unmodified. In contrast, MMP-1 mRNA levels and protein were significantly and similarly increased in cells transfected with TFPI-2 siRNA. In conclusion, this study confirms that TFPI-2 downregulation can contribute to tumour invasion of lung cancer cells.
Insights
Tissue Factor Pathway Inhibitor-2 (TFPI-2) downregulation increases lung cancer cell invasion by upregulating Matrix Metalloproteinase-1 (MMP-1). This study highlights TFPI-2's role in regulating tumor aggressiveness.
Area of Science:
- Molecular Biology
- Cancer Research
- Extracellular Matrix Biology
Background:
- Tissue Factor Pathway Inhibitor-2 (TFPI-2) regulates extracellular matrix (ECM) degradation by inhibiting plasmin, which activates matrix metalloproteinases (MMPs).
- TFPI-2 is often downregulated in aggressive cancers, suggesting a role in tumor invasion and metastasis.
- Understanding TFPI-2's function is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of TFPI-2 in non-small cell lung cancer (NSCLC) cell invasion.
- To determine the impact of TFPI-2 silencing on the expression and activity of various MMPs.
- To elucidate the kinetic effects of TFPI-2 gene silencing and restoration in NSCLC cells.
Main Methods:
- TFPI-2 was silenced in the NCI-H460 NSCLC cell line using small interfering RNA (siRNA).
- Cell invasion and migration were assessed following TFPI-2 silencing.
- mRNA and protein levels, as well as gelatinase activity of MMPs (MMP-1, -2, -3, -9, -14), were analyzed.
- Kinetic studies allowed observation of both gene silencing and restoration effects.
Main Results:
- TFPI-2 silencing significantly increased the invasive potential of NCI-H460 cells, while cell migration remained unaffected.
- TFPI-2 silencing did not alter the mRNA or protein levels of MMP-2, -3, -9, and -14.
- MMP-1 mRNA and protein levels were significantly increased following TFPI-2 silencing, with no change in MMP-2 and MMP-9 gelatinase activity.
Conclusions:
- TFPI-2 downregulation contributes to the increased invasion of lung cancer cells.
- The study identifies MMP-1 as a key mediator in TFPI-2-regulated lung cancer cell invasion.
- These findings underscore the potential of targeting TFPI-2 for managing aggressive lung cancers.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
MicroRNAs
MicroRNAs
Experimental RNAi
lncRNA - Long Non-coding RNAs
